Ezrin expression has also been linked to poor survival in several cancers, including carcinomas of the breast [21], [27], endometrium [28], and ovary [29]; cutaneous and uveal melanomas [30]; and soft tissue sarcomas [31], [32]. This evidence concerns the gene EZR and breast carcinoma.